Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity.

Siva Sundara Kumar Durairajan1, Venkat Reddy Chirasani2, Sravan Gopalakrishnan Shetty3

  • 1Centre for Parkinson's Disease Research, School of Chinese Medicine, Hong Kong Baptist University, No.7, Baptist University Road, Kowloon Tong, Hong Kong. China.

Current Alzheimer Research
|April 18, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Greenhouse gas emissions in natural and degraded tropical peatlands.

iScience·2026
Same author

Gambogic acid induces cell death via covalent binding with PRDX1 to regulate ER stress and autophagy.

Chinese medicine·2026
Same author

Pulmonary neuroendocrine cell-derived exosomes regulate iron homeostasis and oxidative stress in lung neurons.

Science advances·2026
Same author

Biochemical-knowledge-driven machine learning pipeline for generating potent antimicrobial peptides.

Briefings in bioinformatics·2026
Same author

Activation Efficiency and Restoration Effects of SBS Network-Repairing Regenerators on Aged Asphalt.

Materials (Basel, Switzerland)·2026
Same author

Correlation of glycemic variability with the risk of atrial fibrillation and in-hospital mortality in patients diagnosed with obstructive sleep apnea: a retrospective study based on the Medical Information Mart for Intensive Care database.

Journal of thoracic disease·2026

Salvianolic acid B (Sal B) inhibits BACE1, an enzyme crucial in Alzheimer's disease (AD) pathogenesis. This natural compound effectively reduces amyloid-beta (Aβ) peptide production, showing promise as a potential AD therapeutic agent.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) peptide accumulation.
  • Aβ production is primarily driven by β-secretase (BACE1) and γ-secretase enzymes.
  • Inhibiting BACE1 is a key therapeutic strategy for AD.

Purpose of the Study:

  • To investigate salvianolic acid B (Sal B) as a potential BACE1 inhibitor.
  • To evaluate the effect of Sal B on Aβ production in cellular models of AD.

Main Methods:

  • Utilized Swedish APP (SwedAPP) mutant cell lines (N2a-mouse and H4-human neuroglioma).
  • Assessed Aβ, soluble APPβ, and C-terminal fragment β levels.
  • Performed protein-docking simulations to determine Sal B's interaction with BACE1.
Keywords:
Aβ generationBACE-1DockingSalvianolic acid BSoluble amyloid precursor protein-βTraditional Chinese medicine

Related Experiment Videos

Main Results:

  • Sal B significantly and dose-dependently reduced extracellular Aβ generation.
  • Sal B decreased soluble APPβ and intracellular C-terminal fragment β levels.
  • Protein-docking revealed Sal B's interaction with the BACE1 catalytic center, explaining its inhibitory mechanism.

Conclusions:

  • Sal B acts as a BACE1 inhibitor, reducing Aβ production.
  • Sal B demonstrates potential as a therapeutic candidate for Alzheimer's disease.